Get the Stockscreener App
152.07
1.90%
2.83
After Hours:
152.07
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $152.07, with a volume of 471.09K.
It is up +1.90% in the last 24 hours and down -8.29% over the past month.
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$149.24
Open:
$152.69
24h Volume:
471.09K
Relative Volume:
0.82
Market Cap:
$8.09B
Revenue:
$2.04B
Net Income/Loss:
$78.60M
P/E Ratio:
104.88
EPS:
1.45
Net Cash Flow:
$149.60M
1W Performance:
+0.01%
1M Performance:
-8.29%
6M Performance:
+5.80%
1Y Performance:
+13.21%
1-Day Range:
$149.81
$153.50
1-Week Range:
$146.11
$154.31
52-Week Range:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
152.07 | 8.09B | 2.04B | 78.60M | 149.60M | 1.45 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Midday Stock Roundup: US Markets Closed for Good Friday - Orange County Business Journal
Why You Shouldn't Bet Against Masimo (MASI) Stock - Yahoo Finance
Masimo (MASI) Surpasses Q4 Expectations with Robust Revenue Grow - GuruFocus
Here's Why Masimo (MASI) is a Strong Growth Stock - Yahoo Finance
Q4 Patient Monitoring Earnings Review: First Prize Goes To Masimo (NASDAQ:MASI) - Barchart.com
Masimo Shareholder Vote Suit Against Founder Moved To Calif. - Law360
Midday Stock Roundup: First American Financial Down 5.3% - Orange County Business Journal
Masimo Executives to Reveal Latest Business Strategy at Major Healthcare Conference - Stock Titan
Dexcom appoints former Masimo exec as chief commercial officer - HME News
Ex-Masimo CEO Slams Bid To DQ His Hueston Hennigan Attys - Law360
How Is The Market Feeling About Masimo? - Benzinga
Masimo Partners with March of Dimes to Help Parents with Babies in the NICU Make the Transition from Hospital to Home - Quantisnow
Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Yahoo Finance
$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today - Benzinga
West Vancouver Mayor Mark Sager sues clients for $1M - Business in Vancouver
Masimo (MASI): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Masimo corp director sells $341,067 in stock By Investing.com - Investing.com Australia
Masimo corp director sells $341,067 in stock - Investing.com
Masimo Corporation: The Strong Contracting - Smartkarma
Zacks.com featured highlights include Masimo, Robinhood Markets and Discover Financial Services - Yahoo
Charles Schwab Investment Management Inc. Boosts Position in Masimo Co. (NASDAQ:MASI) - Defense World
Masimo’s COO Muhsin Bilal sells over $5 million in stock - Investing.com India
Handheld Multi-Parameter Monitoring Devices Market Size to Cross US$ 5.3 Billion by 2035, Growing at 4.6% CAGR with Rising Demand for Portable Diagnostics – Analysis by TMR - GlobeNewswire Inc.
Masimo Founder Urges Toss Of 'Empty Voting' Suit - Law360
Apple defeats AliveCor bid to block US smartwatch imports in US appeal - Reuters.com
Bank of New York Mellon Corp Sells 4,739 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
Apple Seeks Ban Against Masimo's Original Smartwatch - Law360
Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Joe Kiani Seeks $100M in Statutory Penalties from Masimo - Orange County Business Journal
Apple Says Masimo Kept Selling Smartwatch Despite Claims (1) - Bloomberg Law
Truist Financial Corp Decreases Holdings in Masimo Co. (NASDAQ:MASI) - Defense World
What Will Masimo Reveal at the Raymond James Conference? Key Details for Investors - StockTitan
Masimo Corp. Earnings Call Highlights Robust Growth - TipRanks
Decoding Masimo Corp (MASI): A Strategic SWOT Insight - GuruFocus.com
Masimo Corporation (NASDAQ:MASI) Q4 2024 Earnings Call Transcript - Insider Monkey
BTIG raises Masimo stock price target to $206, maintains buy By Investing.com - Investing.com South Africa
BTIG raises Masimo stock price target to $206, maintains buy - Investing.com
Principal Financial Group Inc. Buys 153 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
Masimo Corp (MASI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - Yahoo Finance
Masimo Corp. Reports Strong Healthcare Growth in 2024 - TipRanks
Masimo: Q4 Earnings Snapshot - The Advocate
Masimo Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Masimo Tops EPS, Revenue Expectations - sharewise
MASIMO CORP SEC 10-K Report - TradingView
Masimo (NASDAQ:MASI) Posts Better-Than-Expected Sales In Q4 - Yahoo Finance
Masimo: Q4 Earnings Snapshot -February 25, 2025 at 04:53 pm EST - Marketscreener.com
Masimo Q4 Non-GAAP Earnings, Revenue Rise; Sets Outlook -February 25, 2025 at 04:36 pm EST - Marketscreener.com
Earnings Flash (MASI) MASIMO Reports Q4 Revenue $600.7M, vs. FactSet Est of $592.6M - Marketscreener.com
Masimo Aims To DQ Hueston Hennigan As Ex-CEO's Counsel - Law360
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):